SCHEMBL8771374

SCHEMBL8771374

Nc1ccc(Cl)cc1C(=O)NCCN1CCOCC1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.69
ALDH1A1 P00352 2/20 0.65
HTR1A P08908 1/20 0.65
MAOA P21397 1/20 0.65
MAOB P27338 1/20 0.65
KCNH2 Q12809 1/20 0.65
CD274 Q9NZQ7 1/20 0.65
HTT P42858 1/20 0.61
LMNA P02545 3/20 0.60
KLK7 P49862 1/20 0.60
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
EPHX2 P34913 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8771387 0.89 ALDH1A1 (0.61) CYP2C19ALDH1A1EPHX2SMN1; SMN2
SCHEMBL26097411 0.86 CYP2C19 (0.67) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL31504829 0.85 CYP2C19 (0.58) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL11486045 0.85 HTT (0.80) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL9410244 0.83 CYP2C19 (0.68) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL26757980 0.83 LMNA (0.78) CYP2C19ALDH1A1MAOBLMNAKMT2A
SCHEMBL11474969 0.81 CYP2C19 (1.00) CYP2C19ALDH1A1HTR1AMAOAMAOB
Hydrochloric Acid SCHEMBL11489984 0.81 CYP2C19 (0.98) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL3540546 0.81 CD274 (0.69) CYP2C19ALDH1A1HTR1AMAOAMAOB
SCHEMBL9760978 0.80 CD274 (0.64) CYP2C19ALDH1A1HTR1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620218-B1 2, 3-Dihydro-4(1H)-quinazolinones active in gastro-intestinal pathologies ALFA WASSERMANN SPA (IT) 1997-10-01 EP disclosed
US-5446152-A Antiemetic agent ALFA WASSERMANN S.P.A. (IT) 1995-08-29 US disclosed
EP-0620218-A1 Heterocyclic compounds active in gastro-intestinal pathologies ALFA WASSERMANN S.p.A. (IT) 1994-10-19 EP disclosed